» Articles » PMID: 23620698

Alterations in Sarcoplasmic Reticulum and Mitochondrial Functions in Diabetic Cardiomyopathy

Overview
Date 2013 Apr 27
PMID 23620698
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Although diabetes due to insulin deficiency or insulin resistance is a major cause of heart disease, the pathogenesis of cardiac dysfunction during the development of diabetic cardiomyopathy is not fully understood. Varying degrees of defects in subcellular organelles, such as sarcolemma, mitochondria, sarcoplasmic reticulum, myofibrils and extracellular matrix have been observed in the diabetic heart. These subcellular abnormalities in chronic diabetes become evident with the occurrence of hormonal imbalance, metabolic defects, oxidative stress and intracellular Ca(2+) overload. During the initial stages of diabetes, hormonal imbalances, including elevated plasma levels of catecholamines and angiotensin II, as well as metabolic defects, appear to favour the development of oxidative stress; these changes lead to subcellular defects in the myocardium. Reductions in sarcoplasmic reticular Ca(2+) pump and Ca(2+) release channel function are associated with cardiac dysfunction, whereas alterations in sarcolemmal Na(+)/Ca(2+) exchanger and Na(+)/K(+) ATPase activities contribute to intracellular Ca(2+) overload at late stages of diabetes. The continued accumulation of Ca(2+) in mitochondria produces Ca(2+) overload in these organelles, and this change induces impairment of energy production and depletion of energy stores as well as further promotion of oxidative stress in chronic diabetes. Generation of oxyradicals due to impaired electron transport results in the opening of mitochondrial pores, leakage of toxic proteins and myocardial cell damage in diabetes. These observations support the view that alterations in sarcoplasmic reticular and mitochondrial functions produce intracellular Ca(2+) overload and depletion of energy stores and, thus, play an important role in the development of cardiac dysfunction in diabetic cardiomyopathy.

Citing Articles

The interplay of inflammation, exosomes and Ca dynamics in diabetic cardiomyopathy.

Sanganalmath S, Dubey S, Veeranki S, Narisetty K, Krishnamurthy P Cardiovasc Diabetol. 2023; 22(1):37.

PMID: 36804872 PMC: 9942322. DOI: 10.1186/s12933-023-01755-1.


High Fasting Glycemia Predicts Impairment of Cardiac Autonomic Control in Adults With Type 2 Diabetes: A Case-Control Study.

Silva L, Gentil P, Seguro C, de Oliveira G, Silva M, Zamuner A Front Endocrinol (Lausanne). 2021; 12:760292.

PMID: 34858333 PMC: 8630737. DOI: 10.3389/fendo.2021.760292.


Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy.

Dhalla N, Shah A, Tappia P Int J Mol Sci. 2020; 21(7).

PMID: 32244448 PMC: 7177292. DOI: 10.3390/ijms21072413.


Calcium Signaling in the Ventricular Myocardium of the Goto-Kakizaki Type 2 Diabetic Rat.

Al Kury L, Smail M, Qureshi M, Sydorenko V, Shmygol A, Oz M J Diabetes Res. 2018; 2018:2974304.

PMID: 29850600 PMC: 5914098. DOI: 10.1155/2018/2974304.


Voltage dependence of the Ca transient in endocardial and epicardial myocytes from the left ventricle of Goto-Kakizaki type 2 diabetic rats.

Al Kury L, Sydorenko V, Smail M, Qureshi M, Shmygol A, Oz M Mol Cell Biochem. 2018; 446(1-2):25-33.

PMID: 29318456 DOI: 10.1007/s11010-018-3269-0.


References
1.
Yan S, Schmidt A, Anderson G, Zhang J, Brett J, Zou Y . Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem. 1994; 269(13):9889-97. View

2.
Taniguchi N, Kaneto H, Asahi M, Takahashi M, Wenyi C, Higashiyama S . Involvement of glycation and oxidative stress in diabetic macroangiopathy. Diabetes. 1996; 45 Suppl 3:S81-3. DOI: 10.2337/diab.45.3.s81. View

3.
Noda N, Hayashi H, Miyata H, Suzuki S, Kobayashi A, Yamazaki N . Cytosolic Ca2+ concentration and pH of diabetic rat myocytes during metabolic inhibition. J Mol Cell Cardiol. 1992; 24(4):435-46. DOI: 10.1016/0022-2828(92)93197-r. View

4.
Ryu S, Beutner G, Dirksen R, Kinnally K, Sheu S . Mitochondrial ryanodine receptors and other mitochondrial Ca2+ permeable channels. FEBS Lett. 2010; 584(10):1948-55. PMC: 2866836. DOI: 10.1016/j.febslet.2010.01.032. View

5.
Stanley W, Recchia F, Lopaschuk G . Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005; 85(3):1093-129. DOI: 10.1152/physrev.00006.2004. View